Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/2445/53340
dc.contributor.author | Danés, Immaculada |
---|---|
dc.contributor.author | Agustí, Antonia |
dc.contributor.author | Vallano Ferraz, Antonio |
dc.contributor.author | Martínez, J. |
dc.contributor.author | Alerany, C. |
dc.contributor.author | Ferrer, A. |
dc.contributor.author | López, A. |
dc.contributor.author | Cortés Hernández, J. |
dc.contributor.author | Bosch, J. A. |
dc.date | 2014-04-08T10:21:14Z |
dc.date | 2014-04-08T10:21:14Z |
dc.date | 2013-09 |
dc.date | 2014-04-08T10:21:14Z |
dc.identifier.citation | 0031-6970 |
dc.identifier.citation | 636712 |
dc.identifier.uri | http://hdl.handle.net/2445/53340 |
dc.format | 11 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | Springer Verlag |
dc.relation | Versió postprint del document publicat a: http://dx.doi.org/10.1007/s00228-013-1518-4 |
dc.relation | European Journal of Clinical Pharmacology, 2013, vol. 69, num. 9, p. 1689-1699 |
dc.relation | http://dx.doi.org/10.1007/s00228-013-1518-4 |
dc.rights | (c) Springer Verlag, 2013 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.subject | Terapèutica |
dc.subject | Medicaments |
dc.subject | Anticossos monoclonals |
dc.subject | Therapeutics |
dc.subject | Drugs |
dc.subject | Monoclonal antibodies |
dc.title | Available evidence and outcome of off-label use of rituximab in clinical practice |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/acceptedVersion |
dc.description.abstract |